Skip to Content

Bleomycin Pregnancy and Breastfeeding Warnings

Bleomycin is also known as: Blenoxane, Bleo 15k

Medically reviewed on August 19, 2016.

Bleomycin Pregnancy Warnings

Bleomycin has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of teratogenicity (e.g., skeletal malformations) in rats. There are no controlled data in human pregnancy; however, use of bleomycin during pregnancy has been associated with fetal harm. If bleomycin is used during pregnancy or if the patient becomes pregnant during treatment, the patient should be advised of the potential hazard to the developing fetus. Women of childbearing potential should be advised to avoid pregnancy during treatment with bleomycin.

See references

Bleomycin Breastfeeding Warnings

There are no data on the excretion of bleomycin into human milk.

See references

References for pregnancy information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. American Medical Association, Division of Toxicology. "Drug Evaluation Annual 1995." Chicago, IL: American Medical Association (1995):
  3. "Product Information. Blenoxane (bleomycin)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  2. "Product Information. Blenoxane (bleomycin)." Bristol-Myers Squibb, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.